Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in <scp>DIAR</scp> mice
Koichi Tsuneyama(Tokushima University), Johji Imura(Saitama Prefectural Kumagaya Girls High School), Shu Taira(Fukui Prefectural University), Takeshi Nishida(Osaka Prefectural Medical Center), Emu Oda(Institute for Animal Reproduction), Shinichi Hayashi(Saitama Cancer Center), Takahiko Nakajima(University of Toyama), Mitsuko Sutoh(Institute for Animal Reproduction), Kazuhiro Nomoto, Makoto Fujimoto(University of Toyama), Hayato Baba(University of Toyama), Ryoji HOKAO(Institute for Animal Reproduction), Shigeharu Miwa(University of Toyama)
Cited by 25
Related Papers
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
|Journal of Infection and Chemotherapy|2012|325
Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
|Journal of Autoimmunity|2008|151
Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis
|Hepatology|2011|124
Cx3cl1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis
|Hepatology|2009|109
The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice
|Journal of Leukocyte Biology|2003|109